Methods for identifying androgen receptor splice variants in subjects having castration resistant prostate cancer
Abstract:
Methods of the present disclosure provide for detection of mutations and splice variants of the androgen receptor using a non-invasive approach, RNAseq, for examining circulating tumor cells.
Information query
Patent Agency Ranking
0/0